Home » Topics » BioWorld Science

BioWorld Science
RSS

New targets, new booster for CAR-T cells

Jan. 15, 2020

Lilly opens enrollment in phase I study of CD73 inhibitor LY-3475070 in advanced cancer

Jan. 14, 2020

Neos studies NT-0502 in pilot phase I trial for chronic sialorrhea

Jan. 14, 2020

Abeona initiates phase III study of EB-101 in recessive dystrophic epidermolysis bullosa

Jan. 14, 2020

FDA approves Valtoco as acute treatment for seizures

Jan. 14, 2020

FDA clears IND for phase Ib/II study of AVB-500 in clear cell renal cell carcinoma

Jan. 14, 2020

Zhejiang Vimgreen Pharma discloses adenosine A2A receptor antagonists

Jan. 14, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

MSD KK receives approval for Pifeltro for treating HIV-1 infection

Jan. 14, 2020

Methylphenidate improves executive functioning in patients with VCI

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...